Onco360, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Geron Corporation for Rytelo™ (imetelstat) for the treatment of adult patients with low to intermediate risk myelodysplastic syndromes (MDS) with transfusion dependent (TD) anemia. Onco360 is excited to be a specialty pharmacy provider for Rytelo™, as it is a great addition to their portfolio of oncology products.